eSource: Not New But Not in Full Force?
eSource is not a new term. But eSource does seem to be getting a lot of attention lately.
eSource is not a new term. But eSource does seem to be getting a lot of attention lately. We have an
Is
eSource could be gaining attention as an outgrowth of the acceptance of risk-based monitoring. Both RBM and eSource Guidances were released by FDA back-to-back in August and September of 2013 respectively.
· Direct entry of data into the eCRF
· Automatic transmission of data from devices or instruments directly to the eCRF
· Transcription of data from paper or electronic sources to the eCRF
· Direct transmission of data from the electronic health record to the eCRF
· Transmission of data from Patient-Reported Outcome (PRO) instruments to the eCRF
So this Guidance connects to RBM in the ways in which companies gather data in real-time to monitor sites more efficiently.
But eSource has been recognized also back in the dark ages of 2004 when a CenterWatch and CDISC survey
Last week,
Is eSource next gen EDC, the real eClinical or a slice of tech life at the site?
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
- Tokenization: The Unsexy Plumbing of Clinical Research
June 24th 2025